Introduction
The resistance of a virus-infected cell to superinfection by the same or by a different virus is known as viral interference. In the life cycle of vesicular stomatitis virus, homologous viral interference (i.e. resistance against the same virus) is mediated by defective interfering particles (Mirakhur & Peluso, 1988; Peluso & Moyer, 1988; Stamminger & Lazzarini, 1989 ). An intracellular immunization against human immunodeficiency virus (HIV) infection via a homologous interference phenomenon was first outlined by Trono et al. (1989) , who demonstrated a reduction in the release of superinfecting HIV-1 from cells harbouring a gag-mutant defective HIV-1 provirus. The failure of any HIV-1 isolate to replicate in HIV-1 chronically infected cells also has been demonstrated by immunological methods (Hart & Cloyd, 1990) . Le Guern & Levy (1992) have observed that both HIV-1 and HIV-2 isolates can superinfect CD4 + HIV-2-infected cells, whereas in clones infected by either of the HIV types and exhibiting the usual CD4 downregulation, superinfection could not be demonstrated. The underlying mechanism(s) of the viral interference was not elucidated since the resistance to HIV-1 superinfection was correlated with the downregulation of CD4 receptor sites mediated by their intracellular binding with the viral gpl60 glycoprotein precursor. No attempts, however, were made to find out whether superinfecting HIVs had or had not entered CD4 downregulated cell clones, as shown by Taddeo et al. (1993) . Conversely, Stevenson et al. (1989) demonstrated only a partial resistance to HIV-1 superinfection occurring in CEM cells transfected with a retrovirus construct expressing high levels of HIV-1 gpl20/gp41, suggesting the presence of other viral and/or cellular factors involved in the interference phenomenon.
We have characterized an HIV-l-infected, non-producer Hut-78 cell clone (F12) harbouring an HIV-1 variant without major genomic changes and exhibiting the usual CD4 downregulation (Federico et al., 1989) . F12 cells are fully resistant to HIV-1 or HIV-2 superinfection, even at high m.o.i. This homologous viral 0001-1664 © 1993 SGM interference appears to be mediated by a block in the retrotranscription of the first DNA strand of superinfecting HIVs .
The possible role of the F12/H1V provirus in the F12 complex phenotype as well as in the homologous viral interference was studied in HIV-l-susceptible CD4 ÷ human cells infected with a recombinant retrovirus harbouring the whole non-producer F12/HIV genome. The SstI/SstI F12/HIV provirus [deprived of both HIV long terminal repeats (LTRs)] was cloned and then subcloned in the pLj (pDOL) retroviral vector (Korman et al., 1987) carrying the neomycin (neo) and Geneticin resistance gene. Amphotropic packaging PA 317 cells (Miller & Buttimore, 1986) were transfected with the F12/HIV-pLj construct and neo-resistant clones were obtained. The supernatants from PA 317 clones were a good source of recombinant retroviruses (carrying the entire F12/HIV genome in either sense or antisense orientation) available for a subsequent abortive cellular infection. F 12/HIV-pLj retrovirus-infected CEMss clones (CEM clones able to form large syncytia 2 to 3 days post-HIV infection), carrying approximately 10 copies/cell of episomal viral DNA without detectable major deletions, exhibited a 1015-to 102-fold reduction in superinfecting HIV-1 yield as compared to CEMss clones carrying the F12/HIV genome in the antisense orientation. Preliminary data suggest that retrotranscription of superinfecting HIV-1 is quantitatively impaired in sense retrovirus-infected CEMss clones.
Methods
Cloning of F12/HIV and insertion in pLj retroviral vector. Total DNA extracted from F12 cells was digested with the SstI enzyme. A fraction of approximately 9 kb was isolated through a 5 to 25 % NaC1 gradient, extensively dialysed, concentrated and then ligated with an SstIdigested pUCI9 plasmid. The screening of transformed JM109 ampicillin-resistant bacterial colonies was performed with a ~2p_ labelled (c~-dCTP, NEN-DuPont, sp. act. 3000 Ci/mmol) SstI/SstI probe excised from the pSp 64/BH10 plasmid.
From a large-scale preparation of F12/HIV-pUC plasmid, the SstI insert was excised and the 3' cohesive ends were converted into blunt ends by the T4 polymerase enzyme (Boehringer Mannheim, BBR). At the same time, the 5' cohesive ends of the BamHI-cut pLj retroviral vector were converted into blunt ends through the 'filling-in' reaction led by the Klenow fragment of DNA polymerase I (BBR), and then dephosphorylated. The transformation of JM109 bacteria with the product of ligation between the pLj vector and the F12/HIV genome gave rise to several kanamycin-resistant colonies, which were screened for sense or antisense orientation of the F12/HIV insert afterwards. An accurate restriction analysis was performed in order to verify the absence of evident deletions or rearrangements in the F12/HIV insert.
Cell cultures, cloning and transfection. CEMss cells, infected or transfected CEMss clones, F12 and 8E. 5 cells were grown in RPMI-1640 medium (Flow Laboratories) with 10 % fetal calf serum (FCS), and were then split biweekly. NIH 3T3 and PA 317 cells were cultured in Dulbecco's modified MEM (Flow) with 10 % FCS. All neo-resistant CEMss clones were maintained in 0.8 mg/ml Geneticin (also designated G418, Sigma) which was about 50% active; while 0.5 mg/ml Geneticin was sufficient to maintain both NIH 3T3 and PA 317 clones.
Transfection experiments were performed using the calcium phosphate co-precipitation method (Wigler et al., 1979) . Cultures were exposed to Geneticin (0"5 mg/ml for both NIH 3T3 and PA 317 cells, 1 mg/ml for CEMss cells) 48 h after transfection. After 15 to 20 days, NIH 3T3 or PA 317 resistant colonies were picked up with vacuum grease-treated cloning cylinders. Conversely, the neo-resistant CEMss cells were cloned by the limiting dilution method in 96-well plates in the presence of 1 mg/ml Geneticin.
Recombinant retrovirus detection and infection of HIV-susceptible cells.
Supernatants from selected PA 317 clones were harvested, clarified at low speed and ultracentrifuged for 8h at 50000g. Retrovirus titres were estimated by infecting polybrene-pretreated (4mg/ml for 6tl) NIH 3T3 cells with serial dilutions of the concentrated preparations. Resistant colonies were scored after 20 days of culture in the presence ofneo. Retrovirus titres were recorded as ricoresistant c.f.u. Polybrene-treated CEMss cells were infected twice with approximately 1 c.f.u./cell and 24 h later were cultivated in the presence of 1 mg/ml Geneticin.
HIV superinfection and detection. Clarified supernatants from Hg/HTLV-III B cells were ultracentrifuged and then used at different concentrations to superinfect CEMss clones. Supernatants of superinfected CEMss clones were collected, clarified and centrifuged in a TL100 Beckman ultracentrifuge at 100000 r.p.m, for 15 rain at 4 °C. Reverse transcriptase (RT) assay was performed as previously described (Rossi et al., 1988) . HIV titres (expressed in syncytiumforming units, s.f.u.) were determined by infecting poly-L-lysinepretreated CEMss cells with serial dilutions of the viral preparations, and by scoring the number of syncytia 4 to 5 days post-infection (p.i.). Electron microscopic analysis was performed as described (Federico et al., 1989) .
Fluorescence-activated cell sorting (FACS) analysis. CD4 receptors on plasma membrane were detected by indirect immunofluorescence analysed by a cytofluorimeter. Briefly, 106 cells were incubated with the appropriate concentration of an anti-CD4 monoclonal antibody (Ortho Diagnostics) in 100 gl PBS containing 2.5 % FCS. After an incubation of 60 min in ice, samples were washed twice in PBS, and further incubated for 60 min in ice with 100 gl of 1:20 goat anti-mouse IgG conjugated with fluorescein isothiocyanate (Ortho Diagnostics). After two washes with PBS, samples were fixed with 3% (v/v) of formaldehyde and analysed in a cytofluorimeter (FAC-scan, Becton Dickinson).
Nucleic acid analysis. Southern and Northern blot analyses were essentially performed as described (Federico et al., 1989) . A 32p_ radiolabelled SstI/SstI F12/HIV insert was used as probe at asp. act. of about 5 x 108 to 8 x 108 c.p.m./pg. Low M r DNA was extracted by the Hirt procedure and digested as indicated in the manufacturer's recommendations.
RNA-PCR analysis was performed on samples treated twice with RNase-free DNase (BBR) followed by heat-inactivation of the DNase and by two phenol-chloroform extractions and ethanol precipitation. Each sample was also checked by DNA-PCR in order to detect the presence of possible DNA contamination. Two-hundred ng of total RNA, extracted by the guanidine isothiocyanate method (Chirgwin et al., 1979) , was retrotranscribed for 90 min at 42 °C in a 20 gl final volume containing 400 units of RNasin, 250 gM of each of the four deoxynucleoside triphosphates, 150 ng of the 'reverse' oligonucleotide primer, 50 units of avian leukosis virus reverse transcriptase (BBR), 50 mM-Tris-HC1 pH 8-3, 3 mM-MgCI~, 60 mM-KC1, 5 mM-DTT and 0.1% (w/v) gelatin. The samples were then denatured and made up to 25 gl by addition of 150 ng of the' forward' oligonucleotide primer and 1 unit of Taq DNA polymerase (Perkin-Elmer Cetus). The amplification was carried out in a Perkin-Elmer Thermocycler for 35 cycles with 2 rain of denaturation at 95 °C, 2 rain of annealing at 55 °C and 3 min of extension at 72 °C. The samples were then run on a 1.8 % agarose gel, transferred to a nylon filter (Hybond-N, Amersham) and hybridized at 42 °C with a 32P-labelled specific oligonucleotide as described (Maniatis et al., 1982) . The filters were then washed for at least 1 h at room temperature in 2x SSPE (SSPE is 0.18 M-NaC1, 0.01 M-NaH~PO 4 pH 7.4, and 0.001 M-EDTA pH 7.4), 0"1% SDS and exposed for 4 to 24 h in a Kodak cassette.
The primers used for the gag region were the 'forward' 5'AGAGATGGTGCGAGAGCGT (overlapping the ATG gag starting codon) named cc 1 ; the' reverse' 5' GTCTAAAGCTTCCTTG-GTGTC, named cc2, 269 nucleotides away from col ; the probe (cc3) in the 'forward' orientation 5'GGGCAAGCAGGGAGCTAGAAC.
The CO 1, CO 2 and CO 3 env-specific primers were also used (Ou et al., 1988) .
Episomal proviral DNA copies/cell were enumerated via a DNA-PCR assay carried out on whole cell lysates of 105 cells of retrovirusinfected sense (C6 and A11) and antisense (D7) clones and of8E. 5 cells used as internal controls; these are known to contain one copy/cell of HIV-I proviral DNA. Cell lysates were serially diluted and a DNA-PCR assay was performed as outlined above, using the HIV-1 gagspecific primers.
PCR assay of HIV-1 superinfection. Two sense and one antisense retrovirus-infected CEMss clones were superinfected with 4 x 103 s.f.u. /106 cells of the HTLV-III B HIV-1 strain. Two days later, 105 cells were DNase-treated for 3 h (to eliminate any possible extracellular HIV DNA contamination), washed three times with an isotonic buffer and lysed in triple-distilled water for 10 min at 95 °C. Proteins were digested with proteinase K (200 ~tg/ml) at 55 °C for 30 min. The enzyme was then inactivated at 95 °C for 10 min. Total cell lysates resulting from this procedure were used for PCR amplification as described above.
For detection of superinfecting HIV-1, primers able to discriminate between v/f sequences of the F12/HIV genome (Carlini et al., 1992) endogenously present in CEMss clones and those of superinfecting H9/IIIB-HIV were utilized. The primer sequences are: 'forward' 5' TAGCACACAAGTAGACCCTGAA (in the F12/HIV sequence the underlined A nucleotides are replaced, respectively, by G and C); 'reverse' 5' TGTCGATTCATTGTGTGGCTCCC (in the F12/HIV sequence the underlined T, C and C nucleotides are replaced, respectively, by A, T and T). The vtfprobe, in the 'forward' orientation, is 5' ATATCAAGCAGGACATAAC. For the mitochondrial DNA, primers previously published were utilized (Wrischnik et al., 1987) .
Protein detection. The F12/HIV-pLj-encoded proteins in PA 317
clones were detected by a p24-specific HIV-1 antigen capture assay (Cellular Products Inc.) performed on 5 × 105 cells lysed in TNE buffer (10 mM-Tri~HC1 pH 8-0, 0.1 M-NaC1, 1 mM-EDTA pH 8-0) containing 0.1% Triton X-100. In retrovirus-infected CEMss clones, F12/HIVrelated proteins were detected by radioimmunoprecipitation assay (RIPA), performed essentially as described (Rossi et aL, 1988) 
Results

Cloning of F12/HIV provirus in p UC19 plasmid and its subcloning in the pLj retroviral vector
An SstI-digested pUC19 plasmid was ligated with the 9 kb fraction of the SstI-digested F12 cellular DNA in order to clone the F12/HIV genome. The SstI/SstI F12/HIV proviral DNA was inserted in both sense and antisense orientations in the pLj retroviral vector, carrying the neo resistance gene (Fig. 1 ). As already described for different HIV-1 isolates (Pescador et al., 1985; Ratner et al., 1985; Srinivasan et al., 1989; WainHobson et al., 1985) , in the F12/HIV variant the SstI restriction sites map in the R regions of LTRs excluding virtually all the regulatory sequences of the 5' LTR and the poly(A) signal of the 3' LTR, but saving all the HIV open reading frames (ORFs). The complete nucleotide sequence of F12/HIV (Carlini et at., 1992) shows that the SstI site is located in the same position in both F12/HIV provirus and the BH10 molecular clone.
Molecular and biological characterization of F12/HIVpLj-transfected PA 317 clones
The amphotropic packaging cell line PA 317 was transfected with the pLj vector or with the F12/HIV-pLj construct in either sense or antisense orientation. Some neo-resistant clones were molecularly and biologically characterized. The F12/HIV-pLj construct integrated into all PA 317 clones analysed ( Fig. 2a ) and retained the integrated F12/HIV-pLj construct even after prolonged cultivation without neo selection pressure. The RNA pattern strongly resembles that observed in parental F12 This was confirmed by hybridizing the same filter with a 'neo'-specific probe (not shown).
cells (Federico et al., 1989) (Fig. 2b) . Conversely, a single b a n d of approximately 13 kb was detected in P A 317 clones transfected with the antisense construct indicating the absence of splicing d o n o r / a c c e p t o r sites in that orientation (not shown).
The ability of several neo-resistant P A 317 clones to release r e c o m b i n a n t retroviral particles was analysed by infecting N I H 3T3 cells with their s u p e r n a t a n t s a n d scoring the neo-resistant colonies. As shown in Table 1 , the retroviral titres of supernatants of F 1 2 / H I V -p L jtransfected clones (in b o t h orientations) were significantly lower (10-to 100-fold) t h a n those of the pLjtransfected ones, possibly because of the large viral genome inserted in the vector. A non-specific inhibitory effect of the F12 genome in either orientation could also n o t be excluded. In any case, supernatants from P A 317 clones, clarified a n d concentrated by ultracentrifugation, were able to infect polybrene-pretreated CEMss cells.
Characterization of CEMss clones infected by the recombinant retrovirus
CEMss cells infected by r e c o m b i n a n t retrovirus preparations (in either sense or antisense orientation) (see Methods) were selected in 0.8 m g / m l Geneticin for a b o u t 20 days. The neo-resistant cell p o p u l a t i o n was then cloned by the limiting dilution m e t h o d and more t h a n 100 clones were recovered.
Southern blot analysis of high M r HindIII-restricted
CEMss D N A , performed on five clones infected with the F 1 2 / H I V -p L j r e c o m b i n a n t sense retrovirus a n d on two clones infected with the antisense F 1 2 / H I V -p L j retro- HIV gag-specific primers were used. As a positive control (C + ), 200 ng of F12 total R N A was processed, and the same amount of uninfected CEMss cellular R N A was the negative control ( C -) . On the left side, the length of the amplified products is shown.
virus, showed that the retrotranscribed viral genome did not integrate into the cellular D N A (Fig. 3) . Southern blot analysis of Hirt-extracted CEMss DNA of four sense and one antisense F12/HIV-pLj clones (Fig. 4a) showed that the F12/HIV D N A sequences had indeed been transferred in all sense and antisense clones tested, but were found only in an unintegrated state even after 20 days of culture with or without selective pressure. This was also verified in Hirt-restricted DNA. The enzymes used were EcoRI, which cuts once in the vpr region of the F12/HIV genome (Carlini et al., 1992) and at the 3" end of the neo resistance gene (see Fig. 1 ), and PvuI, which does not cut in the F12/HIV genome but linearizes the retroviral vector by cutting in the psi region (Fig. 4 c) . It does appear that the abortive infection induced in CEMss cells was due to a recombinant retrovirus not showing major genomic deletions. Similar results were obtained after the recombinant retroviral infection of human or murine cell lines, such as HeLa or N I H 3T3 (data not shown). This suggests that unknown mutation(s) in the integrase sequences and/or function, which occurred in either the F12/HIV genome or in the strain of pLj retroviral vector used (Donehower & Varmus, 1984; Schwartzberg et al., 1984) , may account for its inability to integrate into the host genome. This episomal viral D N A showed a remarkable stability over a > 2 year time interval (Fig. 4 b) .
To assess how many copies of episomal viral DNA/cell were present in sense and antisense retrovirus-infected CEMss clones, a DNA-PCR experiment was carried out on sequentially diluted whole cell lysates of sense (C6, A l l ) and antisense (D7) clones as compared with a similarly diluted whole cell lysate of BE. 5 cells used as a control since they contain only one copy/cell of HIV-1 proviral DNA. Data in Cell lysates from both F12 and D10 clones were used as positive controls, the latter being a producer HIV-1 chronically infected Hut-78 clone (Federico et al., 1989) . 14C-labelled size markers (Amersham) and HIV proteins detectable in RIPA are also marked.
In the retrovirus-infected CEMss cells, both the F12/HIV-pLj (Fig. 4d ) and the neo resistance gene (data not shown) mRNAs were only detectable by RNA-PCR analysis, suggesting a very low transcriptional activity of both Moloney leukaemia virus (MLV) LTRs and simian virus 40 (SV40) promoters present in the unintegrated retroviral vector. Data are shown for gag primers only. When env primers are used two PCR product bands are visible (data not shown). This finding may be accounted for by a preferential overamplification of a single DNA strand which runs with a slight delay with respect to the amplified dsDNA in a non-denaturing gel (J. J. Sninsky, Cetus Corporation, personal communication). At any rate, the specificity of the PCR products is confirmed by the hybridization with the specific oligoprobes.
All sense retrovirus-infected clones showed, as in F12 parental cells, the presence of uncleaved env glycoprotein precursor (three representative clones are shown in Fig.  6 ), whereas the uncleaved p55 gag protein, present in low amounts in F12 cells (Federico et al., 1989) , was not easily detectable in any of the infected CEMss clones. At best, very faint bands were visible on the actual autoradiogram. For the sake of clarity, therefore, all retrovirus-infected clones are scored ( -) in Table 3 with respect to the uncleaved F12 p55. No F12/HIV-specific proteins were detected in CEMss clones infected with the supernatants of PA 317 clones transfected with the F12/HIV-pLj construct in the antisense orientation. As expected, no RT activity was detectable even in 100-fold concentrated supernatants of F12/HIV-pLj retrovirus-infected CEMss clones, since all retrovirusinfected clones were fully non-producer as were F12 cells. Accordingly, RIPA, performed on 10-fold concentrated supernatants of the [aSS]methionine-cysteinelabelled clones, failed to show HIV-specific proteins (not shown). Finally, membrane CD4 receptor sites were equally detectable by the FACS analysis in > 94% retrovirus-infected CEMss cells as in parental CEMss cells. The lower signal shown in Fig. 7 indicates that all retrovirus-infected CEMss cells expose fewer CD4 molecules/cell than the parental uninfected CEMss cells.
HIV-1 challenge of CEMss clones infected with the F12 / HIV-p Lj recombinant retrovirus
Selected clones from the recombinant sense or antisense retrovirus-infected CEMss cells were superinfected with either 2 x 103 or 4 x 103 s.f.u./106 cells. In the absence of the neo selective pressure, HIV-1 yields from CEMss clones carrying the retrovirus-infected antisense F12/ HIV-pLj sequences were comparable to those from HIV-1-infected parental CEMss cells (Table 2) , thus representing the most suitable control for these experiments. In fact, in the F12/HIV-pLj sense retrovirus-infected C6 clone the yields of superinfecting HIV-1 were over 10-fold lower than in the antisense clone D7 (Fig. 8 a) . The magnitude of this effect was higher if the cells were continuously kept under neo selective pressure. Exposure to the antibiotic delayed and reduced HIV-1 production per se in clones infected with the recombinant retrovirus carrying the F12 genome in antisense orientation (Table  2 , compare lines 3 and 2). This may reflect a neo-induced subtle toxicity that was not detected by thymidine, uridine and methionine pulsing of any of three recombinant retrovirus-infected sense (All, C6, D6) and one antisense (D7) CEMss clones tested (data not shown).
In a parallel experiment, duplicate cultures of C6 and D7 clones exposed to 4x 103 s.f.u./10~cells had the antibiotic washed out on day 10 p.i. and were reseeded to monitor virus yields. Removal of Geneticin resulted in markedly increased yields of the superinfecting HIV-1 (as measured by syncytium formation and RT activity) in cultures of the antisense retrovirus-infected D7 clone, as compared to the unwashed cultures of the same clone. Conversely, the low HIV-1 yields from cultures of clone C6 (bearing the sense F12/HIV-pLj retrovirus) did not change as a consequence of the neo removal, again as compared to the unwashed culture of the same clone (Fig. 8b) . Table 2 shows the RT values recorded when the experiment described in Fig. 7(a) was repeated and extended to four other clones (All, B6, D6 and E4) exhibiting the phenomenon of interference and also to the B4 clone, which was shown not to express F12/HIV RNA molecules (see RNA-PCR assay, Fig. 4 d) .
These data were confirmed by electron microscopic observation (data not shown). In the HIV-1-superinfected pLj-infected CEMss G7 clone, a large increase in HIV-1 virions released after neo removal was clearly detected. The absence of intracytoplasmic viral particles in these cells maintained under neo selective pressure rules out the possibility that the increased HIV yields after neo removal were due to a massive release of intracellularly accumulated virions. Instead, very few retroviral particles were released from the HIV-1-superinfected F12/HIV-pLj-infected C6 clone with or without selective pressure.
All RT-positive supernatants obtained from retrovirus-infected CEMss clones after HIV superinfection infected fresh CEMss cells as efficiently as H9/HTLV-III~ supernatants (as indicated by syncytium formation, data not shown), thus proving that superinfected CEMss clones were not releasing defective HIV particles.
In conclusion, HIV protein expression and resistance to HIV superinfection have been detected in all five CD4 + retrovirus-infected clones (All, B6, C6, D6, E4, exhibiting the presence and the expression of sense episomal F12/HIV DNA), but not in CD4 + sense retrovirus-infected clone B4, where the expression of sense episomal F12/HIV DNA was not demonstrated. Controls, consisting of one retrovirus-infected CD4 + clone bearing only the pLj vector (G7), and of two retrovirus-infected CD4 + clones (D7, H9) bearing an antisense episomal F12/HIV DNA, did not show any of the observed phenomena (Table 3) . Both qualitatively and quantitatively, the patterns of F12 proviral expression and resistance to HIV-1 superinfection are similar but not superimposable in the original F12 clone and in the cells carrying the sense F12/HIV-pLj construct. In fact, (i) the former is CD4 downregulated and the latter are CD4 ÷, and (ii) the pattern of F12 proviral expression in F12 cells is both quantitatively (more gpl60) and qualitatively (small but detectable amounts of p55) different from that of the sense clones studied. Further, (iii) the levels of F12 resistance to HIV superinfection are several-fold higher than in sense bioengineered CEMss clones (Table 3) .
PCR analysis of retrotranscription of cDNA in HIV-1 superinfection
In F12 cells, the life cycle of superinfecting HIV-1 and HIV-2 is blocked late during retrotranscription . To determine whether a similar mechanism was operative in superinfected retrovirus-infected sense CEMss clones, lysates from equal numbers of HIV-1-superinfected sense A11 and C6 and antisense D7 CEMss clones were tested by PCR. Taking advantage of some nucleotide mutations in the F12 vfgene (Carlini et al., 1992) , a pair of primers able to discriminate between the endogenous F12/HIV and the superinfecting HIV-1 HXB2 viral genomes was utilized.
Smaller amounts of the retrotranscription products in HIV superinfected clones (sense versus antisense orien- tation) were obtained by serially diluting all cell lysates. As shown in Fig. 9 , the vtfsignal disappears at the 1:32 to 1:64 dilutions in the superinfected sense CEMss clones, whereas the same signal disappears in the superinfected antisense CEMss clone only at the 1:256 dilution. Conversely, in all dilutions of both sense and antisense cell lysates, the mitochondrial DNA could still be amplified. These data correlate well with the difference in superinfecting virus release between sense and antisense CEMss clones, suggesting that the inhibition may occur at a step after virus adsorption but before proviral integration.
Discussion
CD4 downregulation, as a consequence of its intracellular binding to the viral glycoprotein precursor gpl60, may account for the homologous viral interference occurring in HIV-l-infected cells. The existence of CD4-independent modes of HIV cell entry has been outlined by different authors (Ikeuchi et aL, 1990; Li et al., 1990) , who described HIV-1 susceptibility of cells not expressing detectable amounts of CD4 mRNA or protein. Further, the failure of HIV to enter animal cells highly expressing the human CD4 ligand strongly suggests the necessity of other still unknown cellular factors (Chesebro et al., 1990; Maddon et al., 1986) . We tested whether CD4 + HIV-susceptible human cells engineered with the F12/HIV genome would exhibit the same peculiar and complex phenotype as parental CD4-F12 cells and, if they do, whether they were endowed with homologous viral interference. The answers to these questions were unknown since the published data (Federico et al., 1989) did not conclusively show that the F12/HIV genome (and not other unknown cellular factors) was responsible for the F12 phenotype. No viral factor(s) peculiarly encoded by the F12/HIV genome are known, other than those apparently mediating the viral interference occurring in cells productively infected by HIV (Hart & Cloyd, 1990) . The total inability of the F 12/HIV genome to express the full complement of viral proteins was exploited in order to generate bioengineered CD4 + HIV-susceptible cells resistant to HIV-1 infection like the F12 clone but unable to release infectious virus productively.
CEMss cells were infected by recombinant retroviral particles harbouring the F12/HIV genome (in either sense or antisense orientation) in order to test whether cell clones expressing F12/HIV-related proteins were protected against HIV superinfection. All F12/HIV ORFs have been inserted under MLV LTR control. The F12/HIV genome and the neo resistance gene were inserted in the same construct since the cotransfection of an HIV infectious molecular clone with a pNeo plasmid met with failure (Adachi et al., 1986) . Furthermore, we wanted to obtain the correct construct available for a recombinant retrovirus rescue in the absence of regulatory sequences from different promoters (i.e. LTRs from both MLV and HIV). Data shown in Fig. 4 demonstrate that the whole F 12/HIV genome (obviously without its LTRs) was present in the retrovirus-infected F12/HIV-pLj CEMss clones as no major genomic deletions were detected following restriction with EcoRI or PvuI.
As the TAR sequences were excised by the Sstl digestion, the t a t -T A R interaction does not occur in the F12/HIV-pLj construct, which results in the block of any trans-activation (Cullen & Greene, 1989; Dingwall et al., 1989; Gatignol et al., 1989; Sharp & Marciniak, 1989) . It is also conceivable that in CD4 ÷ CEMss cells bearing the F12/HIV-pLj construct several complex interactions among HIV regulatory proteins do not take place. The homologous viral interference detected in F12/HIV-pLj-infected CEMss clones is probably explicable only by the low level expression of F12/HIVrelated structural proteins promoted by the construct.
In the recombinant sense and antisense retrovirusinfected CEMss clones, the retrotranscribed DNA remains in an unintegrated state, probably because of unknown mutation(s) in either the pLj strain (in sites critical for correct integration, such as the inverted repeats at the free ends of the LTRs; Flanagan et al., 1989) or the pol gene of the F12/HIV genome present in the retroviral construct. The episomal state of the F12/HIV-pLj construct may account for the low levels of F12/HIV and neo mRNAs, both detectable only by PCR, particularly if one bears in mind that the infected clones contain approximately 10 copies/cell of (LTR) proviral DNA as compared to the optimal levels of viral transcription in F12 cells that contain only two copies/ cell of (LTR +) proviral DNA (data not shown). A longer half-life of vector-encoded RNAs may explain the bona fide neo resistance and the presence of F 12/HIV antigens. Correct HIV protein production from retroviral DNA in the episomal state has been reported (Stevenson et al., 1990) . As a control, a few neo-resistant non-producer CEMss clones were obtained by directly transfecting the HIV/F12-pLj construct. In these cells, the construct was found to be integrated into the host genome. Northern blot analysis could detect all RNAs encoded by the vector, indicating a higher level of transcription as compared to that occurring in retrovirus-infected CEMss clones. The RIPA of the viral protein pattern, though, was not significantly different from that shown in Fig. 6 . Accordingly, the magnitude of the antiviral effect observed in these clones did not differ from that observed in the retrovirus-infected CEMss clones .
In CEMss clones, the most abundant F12/HIVspecific protein is the uncleaved env gpl60, whose presence correlates with the homologous viral interference shown by the sense clones, whereas the antisense CEMss clones (unable to express env gp160 and showing the same number of copies/cell of episomal proviral DNA) are fully susceptible to HIV superinfection. The preliminary PCR experiments shown in Fig. 9 suggest that a block of superinfecting HIV may take place at a pre-integration level [perhaps similar to the retrotranscription block described by Taddeo et al. (1993) in HIVsuperinfected F12 cells] but other mechanism(s) of inhibition cannot be excluded at the present time. In fact, F12 resistance to HIV superinfection is markedly stronger than in bioengineered CEMss sense clones (Table 3) . This may be due to the higher level of viral protein expression of F12 cells as compared to CEMss clones. Stevenson et al. (1989) observed some resistance to HIV-1 superinfection in CEM cells engineered with a retroviral construct (originating from a producer H1V-1 genome rather than the non-producer F 12/HIV genome) expressing the mature env gpl20 and gp41 products.
The resistance to HIV superinfection of CEMSss clones was maximal if kept under neo selective pressure during superinfection. A possible massive loss of the F12/HIV-pLj construct in neo-deprived cultures may be ruled out by the detection of the retroviral DNA even after 15 days of culture without the antibiotic (data not shown). Rather than a direct effect of the antibiotic on F12/HIV-pLj expression (mRNA production is not impaired by this treatment), the large size of the F12/HIV-pLj retroviral construct may account for its putative intrinsic genetic instability, a property already demonstrated by other retroviral genomes (Omer et al., 1983; Shimotohno & Temin, 1982) . The possible emergence of a few revertants lacking whole or crucial parts of the construct in neo-deprived cell cultures may be hypothesized but not proven because Southern and Northern blot techniques and even PCR analysis are not useful in identifying such revertants.
Yields of superinfecting HIV in antisense-infected clones grown in the presence of neo are lower than in the same clones not exposed to the antibiotic (Table 2) . Following the removal of the antibiotic on day 10 p.i., a sharp increase in RT activity and in syncytium formation was observed. Conversely, in retrovirus-infected CEMss clones, removal of the antibiotic did not result in any increase of the RT activity (Fig. 8 b) . The intracellular immunization induced by the F12/HIV genome may have already prevented HIV superinfection. In these clones, the emergence of revertants after neo removal could be irrelevant.
These results point to the F12/HIV genome as an interesting non-producer interfering HIV genome. Genomic chimeras containing selected fragments of this genome as well as the corresponding parts of an HIV-1 infectious molecular clone may define the portion(s) of the F12 provirus responsible for the F12 phenotype and for the viral interference phenomenon. 
